{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:58:50Z","timestamp":1774353530317,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.humimm.2025.111570","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T10:28:20Z","timestamp":1756981700000},"page":"111570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel and integrated software solution for providing compatible platelets to HLA-sensitized patients"],"prefix":"10.1016","volume":"86","author":[{"given":"Ryan","family":"Morlen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2947-6668","authenticated-orcid":false,"given":"Kevin","family":"Grieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collin","family":"Brack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3951-7760","authenticated-orcid":false,"given":"Krystal","family":"Bullard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-7982","authenticated-orcid":false,"given":"Paula Y.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2025.111570_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101135","article-title":"Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management","volume":"62","author":"Panch","year":"2023","journal-title":"Blood Rev."},{"key":"10.1016\/j.humimm.2025.111570_b0010","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/trf.18036","article-title":"Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review","volume":"64","author":"Panch","year":"2024","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.2023022883","article-title":"How I treat patients who are refractory to platelet transfusions","volume":"145","author":"Nahirniak","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111570_b0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tmrv.2020.09.002","article-title":"Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion","volume":"34","author":"Belizaire","year":"2020","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.humimm.2025.111570_b0025","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.humimm.2018.06.003","article-title":"Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: a multi-center study","volume":"79","author":"Huo","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2025.111570_b0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2003-03-0940","article-title":"Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness","volume":"103","author":"Seftel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111570_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.2830020303","article-title":"Successful transfusion of platelets \u201cmismatched\u201d for HLA antigens to alloimmunized thrombocytopenic patients","volume":"2","author":"Duquesnoy","year":"1977","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2025.111570_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/tme.12612","article-title":"Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patients","volume":"30","author":"Kallon","year":"2020","journal-title":"Transfus. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/trf.15108","article-title":"HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience","volume":"59","author":"Karlstrom","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0055","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/trf.16358","article-title":"Platelet transfusion refractoriness and anti-HLA immunization","volume":"61","author":"Blandin","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0060","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/trf.15333","article-title":"Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients","volume":"59","author":"Gavva","year":"2019","journal-title":"Transfusion"},{"issue":"Suppl 5","key":"10.1016\/j.humimm.2025.111570_b0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/tme.12409","article-title":"HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets","volume":"27","author":"O'Rafferty","year":"2017","journal-title":"Transfus. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/tme.13123","article-title":"Factors affecting the efficacy of human leukocyte antigen-selected platelet provision: a large retrospective study in the United Kingdom","volume":"35","author":"Howell","year":"2025","journal-title":"Transfus. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0075","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1182\/bloodadvances.2024014143","article-title":"Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients","volume":"8","author":"Boothby","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2025.111570_b0080","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/trf.16430","article-title":"Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets","volume":"61","author":"Karafin","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0085","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.5858\/arpa.2021-0051-OA","article-title":"Use of Human Leukocyte Antigen (HLA)-Incompatible Platelet units in HLA Platelet-Refractory patients with Limited Number of or Low-Level HLA Donor-specific Antibodies results in Permissive Transfusions","volume":"146","author":"Sullivan","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"Suppl 5","key":"10.1016\/j.humimm.2025.111570_b0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/tme.12412","article-title":"Platelet donor selection for HLA-immunised patients; the impact of donor-specific HLA antibody levels","volume":"27","author":"Linjama","year":"2017","journal-title":"Transfus. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1537-2995.2007.01516.x","article-title":"Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?","volume":"48","author":"Duquesnoy","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0100","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2004-10-4080","article-title":"HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients","volume":"107","author":"Nambiar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111570_b0105","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1537-2995.2008.01837.x","article-title":"Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions","volume":"48","author":"Brooks","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0110","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/j.1537-2995.2010.02703.x","article-title":"Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases","volume":"50","author":"Pai","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood.2020007199","article-title":"An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial","volume":"137","author":"Marsh","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111570_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/tme.12670","article-title":"Identifying human leukocyte antigen (HLA)-compatible platelets using the Matchmaker programme in alloimmunised platelet-refractory patients","volume":"30","author":"Kreuter","year":"2020","journal-title":"Transfus. Med."},{"key":"10.1016\/j.humimm.2025.111570_b0125","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/trf.16025","article-title":"Development and performance characteristics of Platelet Virtual Crossmatch (PLT VXM), a software application for the evaluation and management of platelet transfusion-refractory patients","volume":"60","author":"Juskewitch","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0130","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/vox.13565","article-title":"Virtual platelet cross-matching as transfusion management for patients with immune platelet refractoriness","volume":"119","author":"Bonet-Bub","year":"2024","journal-title":"Vox Sang."},{"key":"10.1016\/j.humimm.2025.111570_b0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0198-8859(94)90270-4","article-title":"Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients","volume":"39","author":"Rodey","year":"1994","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2025.111570_b0140","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2006-06-032193","article-title":"HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation","volume":"109","author":"Wade","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2025.111570_b0145","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/trf.15530","article-title":"HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening","volume":"59","author":"Kreuger","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.humimm.2025.111570_b0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.coi.2008.06.010","article-title":"Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation","volume":"20","author":"Duquesnoy","year":"2008","journal-title":"Curr. Opin. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:01:16Z","timestamp":1762264876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925003416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0198885925003416"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111570","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel and integrated software solution for providing compatible platelets to HLA-sensitized patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111570"}}